32 Biosciences receives $6 million in funding to advance gut microbiome platform technologies

32 Biosciences announced it has received $6 million in funding to support the continued development of its lead assets. The funding comes as the company prepares for a future Series A fundraise and advances toward key regulatory milestones. The post 32 Biosciences receives $6 million in funding to advance gut microbiome platform technologies appeared first on 32 Bio Sciences .